Literature DB >> 25673630

Atrial fibrosis and conduction slowing in the left atrial appendage of patients undergoing thoracoscopic surgical pulmonary vein isolation for atrial fibrillation.

Sébastien P J Krul1, Wouter R Berger1, Nicoline W Smit1, Shirley C M van Amersfoorth1, Antoine H G Driessen1, Wim Jan van Boven1, Jan W T Fiolet1, Antoni C G van Ginneken1, Allard C van der Wal1, Jacques M T de Bakker1, Ruben Coronel1, Joris R de Groot2.   

Abstract

BACKGROUND: Atrial fibrosis is an important component of the arrhythmogenic substrate in patients with atrial fibrillation (AF). We studied the effect of interstitial fibrosis on conduction velocity (CV) in the left atrial appendage of patients with AF. METHODS AND
RESULTS: Thirty-five left atrial appendages were obtained during AF surgery. Preparations were superfused and stimulated at 100 beats per minute. Activation was recorded with optical mapping. Longitudinal CV (CVL), transverse CV (CVT), and activation times (> 2 mm distance) were measured. Interstitial collagen was quantified and graded qualitatively. The presence of fibroblasts and myofibroblasts was assessed immunohistochemically. Mean CVL was 0.55 ± 0.22 m/s, mean CVT was 0.25 ± 0.15 m/s, and the mean activation time was 9.31 ± 5.45 ms. The amount of fibrosis was unrelated to CV or patient characteristics. CVL was higher in left atrial appendages with thick compared with thin interstitial collagen strands (0.77 ± 0.22 versus 0.48 ± 0.19 m/s; P = 0.012), which were more frequently present in persistent patients with AF. CVT was not significantly different (P = 0.47), but activation time was 14.93 ± 4.12 versus 7.95 ± 4.12 ms in patients with thick versus thin interstitial collagen strands, respectively (P = 0.004). Fibroblasts were abundantly present and were associated with the presence of thick interstitial collagen strands (P = 0.008). Myofibroblasts were not detected in the left atrial appendage.
CONCLUSIONS: In patients with AF, thick interstitial collagen strands are associated with higher CVL and increased activation time. Our observations demonstrate that the severity and structure of local interstitial fibrosis is associated with atrial conduction abnormalities, presenting an arrhythmogenic substrate for atrial re-entry.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  action potential optical mapping; atrial appendage; atrial fibrillation; atrial remodeling; electrophysiology; fibrosis

Mesh:

Substances:

Year:  2015        PMID: 25673630     DOI: 10.1161/CIRCEP.114.001752

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  34 in total

1.  Association of Left Atrial Local Conduction Velocity With Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.

Authors:  Kotaro Fukumoto; Mohammadali Habibi; Esra Gucuk Ipek; Sohail Zahid; Irfan M Khurram; Stefan L Zimmerman; Vadim Zipunnikov; David Spragg; Hiroshi Ashikaga; Natalia Trayanova; Gordon F Tomaselli; John Rickard; Joseph E Marine; Ronald D Berger; Hugh Calkins; Saman Nazarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-03

2.  Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K+ -current block in atrial fibrillation.

Authors:  Haibo Ni; Alex Fogli Iseppe; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang; Andrew G Edwards; Stefano Morotti; Eleonora Grandi
Journal:  Br J Pharmacol       Date:  2020-08-09       Impact factor: 8.739

Review 3.  What Is the Role of Left Atrial Appendage Closure in the Rhythm Control of Atrial Fibrillation?

Authors:  Albert C Lin; Bradley P Knight
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-06

4.  Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.

Authors:  Pedro Pinto Teixeira; Mário Martins Oliveira; Ruben Ramos; Pedro Rio; Pedro Silva Cunha; Ana Sofia Delgado; Ricardo Pimenta; Rui Cruz Ferreira
Journal:  J Interv Card Electrophysiol       Date:  2017-05-31       Impact factor: 1.900

5.  Investigation of the atrial conduction time measured by tissue Doppler imaging at the left atrial appendage and the actual electrical conduction time: consideration of left atrial remodeling in atrial fibrillation patients.

Authors:  Yuichi Hori; Shiro Nakahara; Naofumi Anjo; Ayako Nakagawa; Naoki Nishiyama; Kouta Yamada; Akiko Hayashi; Takaaki Komatsu; Sayuki Kobayashi; Yoshihiko Sakai; Isao Taguchi
Journal:  J Interv Card Electrophysiol       Date:  2016-09-22       Impact factor: 1.900

6.  Diverse Fibrosis Architecture and Premature Stimulation Facilitate Initiation of Reentrant Activity Following Chronic Atrial Fibrillation.

Authors:  Nathan Angel; L I Li; Rob S Macleod; Nassir Marrouche; Ravi Ranjan; Derek J Dosdall
Journal:  J Cardiovasc Electrophysiol       Date:  2015-09-11

Review 7.  Computational modeling of cardiac fibroblasts and fibrosis.

Authors:  Angela C Zeigler; William J Richardson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2015-12-01       Impact factor: 5.000

Review 8.  Comprehensive evaluation of electrophysiological and 3D structural features of human atrial myocardium with insights on atrial fibrillation maintenance mechanisms.

Authors:  Aleksei V Mikhailov; Anuradha Kalyanasundaram; Ning Li; Shane S Scott; Esthela J Artiga; Megan M Subr; Jichao Zhao; Brian J Hansen; John D Hummel; Vadim V Fedorov
Journal:  J Mol Cell Cardiol       Date:  2020-10-29       Impact factor: 5.000

Review 9.  Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail.

Authors:  Summer Hassan; Carolyn J Barrett; David J Crossman
Journal:  Biophys Rev       Date:  2020-07-23

10.  Using Machine Learning to Characterize Atrial Fibrotic Substrate From Intracardiac Signals With a Hybrid in silico and in vivo Dataset.

Authors:  Jorge Sánchez; Giorgio Luongo; Mark Nothstein; Laura A Unger; Javier Saiz; Beatriz Trenor; Armin Luik; Olaf Dössel; Axel Loewe
Journal:  Front Physiol       Date:  2021-07-05       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.